FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W65190219> ?p ?o ?g. }

• W65190219 endingPage "9" @default.
• W65190219 startingPage "543" @default.
• W65190219 abstract "Knee osteoarthritis is a major cause of disability in the elderly. Many therapies are nowadays available, ranging from non-pharmacologic to pharmacological approaches like visco-supplementation, oral supplements or topical treatments, but a flawless treatment is still to be found. Visco-supplementation represents a valid treatment option for reducing pain associated with knee osteoarthritis and improving function in the affected joint. Many literature data report on the efficacy and safety profiles of hyaluronic acid in knee osteoarthritis, however the efficacy of intra-articular hyaluronic acid remains controversial, in fact while several clinical trials claimed a disease-modifying effect for hyaluronic acid, subsequent meta-analyses have cast doubts on this fact. The ideal intra-articular treatment for osteoarthritis should not only provide a mechanical protection of the cartilage surface, but also restore condrocytes’ homeostasis by restoring the physiological articular micro-environment and supplying nutrients. In this perspective an innovative medical product made up of polynucleotides (Condrotide) has been developed. The aim of this study is to test the 2-months efficacy in pain relief and improving function of intra-articular injections of Condrotide in patients with knee osteoarthritis or with grade III or IV chondropathy. Ninety-five subjects (33 men, 62 women), aged between 53 and 80, were included between May 2011 to July 2012. All subjects received intra-articular injections of Condrotide and were evaluated with the Knee injury and Osteoarthritis Outcome Score (KOOS), the NRS scale for pain assessment, the measurement of the range of motion (R.O.M.). In all subjects a significant improvement was found in KOOS score after 60 days. The mean global NRS pain decreased in both groups and there was also a R.O.M. improvement. These results show that the intra-articular administration of nucleotides in subjects with both severe knee arthritis and chondropathy can be recommended since is able to reverse in the short and medium term symptoms and function with a significant improvement in quality of life." @default.
• W65190219 created "2016-06-24" @default.
• W65190219 creator A5015672840 @default.
• W65190219 creator A5019767774 @default.
• W65190219 creator A5040904145 @default.
• W65190219 creator A5059987642 @default.
• W65190219 creator A5063342201 @default.
• W65190219 date "2013-07-09" @default.
• W65190219 modified "2023-09-27" @default.
• W65190219 title "Intrarticular treatment of osteoartropaty knee with polynucleotides: a pilot study with medium-term follow-up." @default.
• W65190219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23830403" @default.
• W65190219 hasPublicationYear "2013" @default.
• W65190219 type Work @default.
• W65190219 sameAs 65190219 @default.
• W65190219 citedByCount "4" @default.
• W65190219 countsByYear W651902192014 @default.
• W65190219 countsByYear W651902192017 @default.
• W65190219 countsByYear W651902192022 @default.
• W65190219 countsByYear W651902192023 @default.
• W65190219 crossrefType "journal-article" @default.
• W65190219 hasAuthorship W65190219A5015672840 @default.
• W65190219 hasAuthorship W65190219A5019767774 @default.
• W65190219 hasAuthorship W65190219A5040904145 @default.
• W65190219 hasAuthorship W65190219A5059987642 @default.
• W65190219 hasAuthorship W65190219A5063342201 @default.
• W65190219 hasConcept C105702510 @default.
• W65190219 hasConcept C126322002 @default.
• W65190219 hasConcept C141071460 @default.
• W65190219 hasConcept C142724271 @default.
• W65190219 hasConcept C1862650 @default.
• W65190219 hasConcept C204787440 @default.
• W65190219 hasConcept C2776164576 @default.
• W65190219 hasConcept C2777529286 @default.
• W65190219 hasConcept C2779985480 @default.
• W65190219 hasConcept C2908736133 @default.
• W65190219 hasConcept C2909830753 @default.
• W65190219 hasConcept C3019843197 @default.
• W65190219 hasConcept C3020332539 @default.
• W65190219 hasConcept C535046627 @default.
• W65190219 hasConcept C71924100 @default.
• W65190219 hasConceptScore W65190219C105702510 @default.
• W65190219 hasConceptScore W65190219C126322002 @default.
• W65190219 hasConceptScore W65190219C141071460 @default.
• W65190219 hasConceptScore W65190219C142724271 @default.
• W65190219 hasConceptScore W65190219C1862650 @default.
• W65190219 hasConceptScore W65190219C204787440 @default.
• W65190219 hasConceptScore W65190219C2776164576 @default.
• W65190219 hasConceptScore W65190219C2777529286 @default.
• W65190219 hasConceptScore W65190219C2779985480 @default.
• W65190219 hasConceptScore W65190219C2908736133 @default.
• W65190219 hasConceptScore W65190219C2909830753 @default.
• W65190219 hasConceptScore W65190219C3019843197 @default.
• W65190219 hasConceptScore W65190219C3020332539 @default.
• W65190219 hasConceptScore W65190219C535046627 @default.
• W65190219 hasConceptScore W65190219C71924100 @default.
• W65190219 hasIssue "2" @default.
• W65190219 hasLocation W651902191 @default.
• W65190219 hasOpenAccess W65190219 @default.
• W65190219 hasPrimaryLocation W651902191 @default.
• W65190219 hasRelatedWork W132341038 @default.
• W65190219 hasRelatedWork W1831989259 @default.
• W65190219 hasRelatedWork W1987314451 @default.
• W65190219 hasRelatedWork W2332434854 @default.
• W65190219 hasRelatedWork W2351180963 @default.
• W65190219 hasRelatedWork W263899766 @default.
• W65190219 hasRelatedWork W2795856267 @default.
• W65190219 hasRelatedWork W4281658347 @default.
• W65190219 hasRelatedWork W65190219 @default.
• W65190219 hasRelatedWork W2181732343 @default.
• W65190219 hasVolume "27" @default.
• W65190219 isParatext "false" @default.
• W65190219 isRetracted "false" @default.
• W65190219 magId "65190219" @default.
• W65190219 workType "article" @default.